HB 1533 (the Crown and Care Act) bans 12 specific harmful ingredients - including certain phthalates, formaldehyde, mercury, and PFAS chemicals - from cosmetic products sold in Maryland. It directly affects cosmetic manufacturers, retailers, and salons by prohibiting the sale or distribution of products containing these ingredients, with limited exceptions for unavoidable trace amounts from manufacturing processes. The bill authorizes the Maryland Department of Health to investigate complaints, inspect businesses, and enforce penalties, while allowing consumers harmed by violations to seek civil damages and attorney fees. This law aims to protect public health by reducing exposure to chemicals linked to health risks like skin irritation and potential long-term harm.
SB 656 bans 12 specific harmful chemicals in cosmetics sold in Maryland, including formaldehyde, mercury, and certain PFAS chemicals. It creates civil liability for manufacturers or sellers who violate this ban, allowing consumers to sue for damages. The Maryland Department of Health gains authority to investigate complaints, inspect businesses, and collect product samples. The law exempts trace amounts of banned ingredients that occur unavoidably during manufacturing. The bill takes effect July 1, 2026.
HB 1135 allows pharmacists in Maryland to order certain vaccinations for patients aged 3 and older without needing to administer the vaccine themselves. Pharmacists must complete 20+ hours of approved training covering vaccine safety, injection techniques, and emergency response, hold current CPR certification, and report all vaccinations to the ImmuNet program. The bill specifically covers influenza, COVID-19, and emergency-use vaccines, and requires pharmacists to refer minors to pediatric care when ordering vaccines. This expands pharmacists' role in vaccine access while maintaining safety protocols and reporting requirements.
SB 773 allows pharmacists in Maryland to order certain vaccinations (like flu, COVID-19, or emergency vaccines) for patients aged 3 and older without needing to administer the vaccine themselves. To qualify, pharmacists must complete 20 hours of approved training, hold current CPR certification, and complete 2 hours of continuing education on immunizations. The bill requires pharmacists to follow written vaccine-specific protocols, report all vaccinations to Maryland’s ImmuNet registry, and refer pediatric patients to primary care providers when appropriate. This policy directly affects pharmacists, patients seeking these vaccines, and healthcare coordination for immunizations. The changes take effect October 1, 2026.
SB 439 prohibits Maryland fire and rescue public safety employers from taking negative employment actions (like firing or denying promotions) against employees who use medical cannabis, provided the employee has a valid medical cannabis certification under state law. It amends existing Maryland law to explicitly add this protection for public safety workers, aligning with current medical cannabis certification requirements. The bill does not change how medical cannabis is certified but ensures these employees cannot face discrimination solely for using cannabis legally under the state program. This applies to all fire and rescue employees who meet the state's medical cannabis eligibility criteria.
SB 385 (The Vax Act) requires Maryland’s Secretary of Health to issue evidence-based recommendations for immunizations, screenings, and preventive services, aligning with guidance from major medical organizations like the CDC and U.S. Preventive Services Task Force. It expands pharmacists’ authority to administer vaccines (including those recommended by CDC or the Secretary) to patients aged 3+ after completing specific training and certification, while mandating health insurers to cover these services without cost-sharing. The bill also repeals outdated pertussis-related provisions and updates reporting requirements for pharmacists. This directly affects pharmacists, health insurers, and patients seeking preventive care, aiming to improve access to vaccinations and screenings.
HB 637 ("The Vax Act") requires Maryland's Secretary of Health to issue science-based recommendations for immunizations, screenings, and preventive services using guidance from major medical organizations like the CDC and American Academy of Pediatrics. It expands pharmacists' authority to administer flu, COVID-19, and emergency vaccines to patients aged 3 and older (previously limited to 18+ for some vaccines) after completing specific training. The bill also mandates that health insurance plans cover these recommended services without cost-sharing for patients. This directly affects pharmacists, health insurers, and Maryland residents seeking preventive care, particularly children and adults needing routine vaccinations.
HB 498 removes an existing exemption that allowed intermediate care facilities providing substance use disorder treatment to change bed capacity without a certificate of need. It specifically targets facilities offering "medically managed residential substance use disorder treatment services," requiring them to file 45 days' written notice with the health commission before operating or expanding. The commission must then review and approve these changes based on whether they align with the state health plan, improve service efficiency, and serve the public interest. This bill directly affects facilities providing residential substance use treatment by adding a review process for bed capacity changes or new operations, replacing the previous exemption.
SB 790, the Public Health Reform Act, requires the Maryland Department of Health to organize the Maryland Medical Reserve Corps - a statewide volunteer network for emergencies like disease outbreaks or disasters. It allows county health directors to hire staff without state approval if positions are fully funded locally and to enter contracts if the state fails to respond within a set timeframe. The bill creates the Public Health Workforce Development Fund (using interest earnings and transfers from another fund) to support workforce training, and mandates health equity impact assessments for new legislation. These changes directly affect county health departments, state health agencies, and public health emergency response systems.
SB 504 prohibits businesses from selling consumer personal data to buyers who intend to use it for immigration enforcement. It defines "sensitive data" to include immigration status, racial origin, health information, and sexual orientation, requiring businesses to handle such data more carefully. The bill also mandates public record custodians to prevent unauthorized disclosure - especially for immigration enforcement - and requires message switching systems to implement access controls. These changes aim to strengthen privacy protections for Maryland residents while modifying existing data privacy laws in the state code.
